๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
The purpose of this study is to evaluate the safety and efficacy of rebamip...
Status
Completed
Location
The Eye Care Group, P.C.
Start Date
2009-12
Trial ID
NCT01027013
Treatments Being Tested
The purpose of this study is to evaluate the dose-response of OPC-12759 sus...
Status
Completed
Location
Multiple Locations
Start Date
2007-05
Trial ID
NCT00475319
Treatments Being Tested
The purpose of this study is to assess the safety of OPC-12759 ophthalmic s...
Status
Completed
Location
Kansai region
Start Date
2011-11
Trial ID
NCT01471093
Treatments Being Tested
The purpose of this study is to evaluate safety and efficacy of OPC-12759 o...
Status
Completed
Location
Multiple Locations
Start Date
2009-01
Trial ID
NCT00818324
Treatments Being Tested
The purpose of this study is to verify whether OPC-12759 ophthalmic suspens...
Status
Completed
Location
Kyushu region
Start Date
2009-05
Trial ID
NCT00885079
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of OPC-12759 ophthalm...
Status
Completed
Location
Kanto region
Start Date
2011-12
Trial ID
NCT01493180
Treatments Being Tested
Two-period, controlled, randomized and open clinical trial. The sample was ...
Status
Completed
Location
Hospital Nacional Profesor A. Posadas
Start Date
2017-02-06
Trial ID
NCT03608761
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of 2% reba...
Status
Completed
Location
East Valley Ophthalmology
Start Date
2010-02
Trial ID
NCT01057147
Treatments Being Tested
The purpose of this study is to evaluate the dose-response of OPC-12759 oph...
Status
Completed
Location
Otsuka Pharmaceutical Co., Ltd.
Start Date
2005-01
Trial ID
NCT00234078
Treatments Being Tested